Latest total revenue for TSVT: $48M, below the sector sector average of $1.3B.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2025
Trailing 12 months ending Mar 2025
As of the most recent data (March 2025), TSVT shows a total revenue of $48M. That compares with $71M in the prior-year period — down 32.1% year over year. That is below the sector sector average of $1.3B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, TSVT's total revenue is now $48M (was $71M) — a 32.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 2seventy bio is outperforming or lagging.
The its sector sector average total revenue is about $1.3B. 2seventy bio is at $48M, which is lower that average. That is roughly 96.3% below the sector mean. Use the comparison chart on this page to see how TSVT stacks up against individual peers as well.
Tracking TSVT's total revenue over time shows whether 2seventy bio is scaling, shrinking, or reshaping that part of the business. The current reading is $48M That compares with $71M in the prior-year period — down 32.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has 2seventy bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $48M) with ownership activity and broader fundamentals.